At siRNAgen, we’re here to help you achieve high-quality, scalable, and cost-effective oligonucleotide production through innovative, end-to-end solutions tailored to your needs.
Our platform supports every step of oligonucleotide API manufacturing — from early preclinical stages to full-scale commercial production.
With deep expertise in analytical development, process optimization, and quality management, we work alongside you to bring your projects to success.
We specialize in developing and scaling up a wide range of therapeutic oligos, including ASO, siRNA, aptamers, oligo conjugates, PMO, and PPMO.
We continuously invest in new technologies to improve quality and reduce costs for our clients.
We collaborate with clients on method development, tech transfer, validation, and ICH stability studies — helping prepare CMC documentation that meets regulatory requirements.
Our lab is equipped with advanced instruments to analyze everything from raw materials and intermediates to APIs and adjuvants.
From small-scale research batches to commercial-scale production, our facility can handle synthesis and downstream processing of oligonucleotides up to 120 mmol — with flexibility to meet your project’s scale.
Our state-of-the-art QC lab ensures strict quality testing of raw materials, intermediates, crude APIs, and finished drug substances.
We’re committed to delivering the highest standards of quality that you can rely on.
If you contact us (orders@sirnagen.com), we will promptly provide you with information on oligonucleotide synthesis specifications, scale options, and a quotation.